Methotrexate-Ebeve

Methotrexate-EBEVE: An antimetabolite for the effective treatment of various diseases

Methotrexate-EBEVE is a pharmaceutical drug used to treat various diseases. It belongs to the group of antimetabolites - analogues of folic acid. Methotrexate-EBEVE is produced by Ebewe Pharma GmbH in Austria and is widely used in medical practice.

Methotrexate, also known by its international name, is the active ingredient of the drug. It is available in a variety of dosage forms, including tablets of varying strengths, concentrates for infusion, and solutions for injections. This allows doctors to choose the most appropriate form and dosage for each patient.

Methotrexate-EBEVE is used to treat a wide range of diseases. It is effective for uterine chorionic carcinoma, chorioadenoma, acute lymphocytic leukemia, breast cancer, epidermoid cancer of the head and neck, lung cancer, Hodgkin's disease and non-Hodgkin's lymphoma, osteosarcoma, psoriasis, rheumatoid arthritis, bronchial asthma (steroid-dependent form), juvenile rheumatoid arthritis, Felty's syndrome, Reiter's syndrome, graft-versus-host disease, Crohn's disease, ulcerative colitis, lichen planus, mycosis fungoides (topical treatment), psoriatic arthritis, reticular erythroderma, neuroleukemia and Sézary's syndrome.

However, there are some contraindications to the use of Methotrexate-EBEVE. This drug is not recommended for hypersensitivity to methotrexate, immunodeficiency, anemia (including hypo- and aplastic), leukopenia, thrombocytopenia, liver disease, pregnancy and lactation. It is important to discuss all contraindications and potential risks with your doctor before starting treatment.

Side effects may occur when using Methotrexate-EBEVE. Some of them include headache, blurred vision, drowsiness, aphasia, paresis, seizures, interstitial pneumonitis, gingivitis, pharyngitis, ulcerative stomatitis, anorexia, nausea, vomiting, diarrhea, melena, ulceration of the gastric and intestinal mucosa, increased liver enzymes, alopecia , skin rash, photosensitivity, decreased number of leukocytes and platelets, anemia and others. It is important to monitor the patient carefully while taking this drug and report any unwanted effects to the doctor.

The dosage of Methotrexate-EBEVE and the duration of treatment depend on the specific disease and individual characteristics of the patient. Your doctor should provide precise recommendations on dosage and treatment regimen.

In conclusion, Methotrexate-EBEVE is an effective drug used in the treatment of various diseases. However, its use should be under the supervision of a physician, taking into account contraindications and side effects. If you have any questions or doubts, it is recommended that you contact a medical professional for detailed information and advice.